top of page


Between invention and impact: what INPI and GII data reveal about the urgency of health innovation in Brazil
In recent years, Brazil has faced a persistent paradox: it produces ever-increasing amounts of science, but continues to transform little...
Oct 86 min read
Â
Â
Â


COINFAR: Pioneering in Biotechnology and the Opportunity to Restore a Cooperative Model in Brazil
How to revive the cooperative model that can transform Brazil into a biotechnology powerhouse When I received the invitation in 2005 to...
Aug 245 min read
Â
Â
Â


Global Pharmaceutical Innovation to 2029: Trends, Challenges and Brazil's Place
The global pharmaceutical and biotechnology industry is experiencing a period of accelerated growth in drug use and spending, driven by...
Jul 1630 min read
Â
Â
Â


FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
Jun 2330 min read
Â
Â
Â
bottom of page
